Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28555630)

Published in Am J Gastroenterol on May 30, 2017

Authors

Douglas K Rex1, C Richard Boland2, Jason A Dominitz3, Francis M Giardiello4, David A Johnson5, Tonya Kaltenbach6, Theodore R Levin7, David Lieberman8, Douglas J Robertson9

Author Affiliations

1: Indiana University School of Medicine, Indianapolis, Indiana, USA.
2: University of California San Diego, San Diego, California, USA.
3: VA Puget Sound Health Care System, University of Washington, Seattle, Washington, USA.
4: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
5: Eastern Virginia Medical School, Norfolk, Virginia, USA.
6: San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
7: Kaiser Permanente Medical Center, Walnut Creek, California, USA.
8: Oregon Health and Science University, Portland, Oregon, USA.
9: VA Medical Center, White River Junction, Vermont, and Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.

Associated clinical trials:

Effectiveness and Implementation of mPATH-CRC | NCT03843957

Real-World Validation of an Artificial Intelligence Characterization Support (CADx) System | NCT05034185

Articles cited by this

(truncated to the top 100)

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med (1993) 21.18

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med (2012) 16.55

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86

Association of colonoscopy and death from colorectal cancer. Ann Intern Med (2008) 15.51

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50

The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med (2000) 13.19

Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86

American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16

Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 11.76

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48

Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 11.07

Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med (2006) 10.52

Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63

Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54

Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med (2011) 6.50

Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer (2013) 6.23

A prospective study of family history and the risk of colorectal cancer. N Engl J Med (1994) 6.12

Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA (2008) 5.94

Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol (2011) 5.72

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (2009) 5.69

Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol (2007) 4.62

Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med (2004) 4.49

Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med (2012) 4.47

Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology (1997) 4.32

Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22

Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology (2012) 4.13

Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med (2013) 4.07

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA (2016) 4.06

Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol (2009) 3.96

The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology (2010) 3.87

Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83

Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med (2012) 3.79

Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE. J Natl Cancer Inst (2011) 3.75

Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Ann Intern Med (2015) 3.45

CT colonography reporting and data system: a consensus proposal. Radiology (2005) 3.43

Obesity and colorectal cancer. Gut (2013) 3.29

Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology (2013) 3.25

Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol (2009) 3.20

A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. Med J Aust (2006) 3.20

Colorectal cancer in African Americans. Am J Gastroenterol (2005) 3.18

Vital signs: colorectal cancer screening test use--United States, 2012. MMWR Morb Mortal Wkly Rep (2013) 3.12

Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med (2002) 3.11

Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst (2010) 3.05

Race, ethnicity, and sex affect risk for polyps >9 mm in average-risk individuals. Gastroenterology (2014) 3.03

Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol (2012) 2.77

Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet (2013) 2.72

ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc (2006) 2.63

A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst (2005) 2.60

Meta-analysis comparing CT colonography, air contrast barium enema, and colonoscopy. Am J Med (2007) 2.57

Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst (2005) 2.51

Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol (2010) 2.44

Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol (2014) 2.41

Colonic neoplasia in patients with nonspecific GI symptoms. Gastrointest Endosc (2000) 2.39

Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clin Gastroenterol Hepatol (2013) 2.37

Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol (2010) 2.34

Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med (2014) 2.31

Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol (2010) 2.26

Cost-effectiveness of colorectal cancer screening. Epidemiol Rev (2011) 2.24

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut (2013) 2.17

Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15

Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06

Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists. Endoscopy (2016) 2.03

Optical colonoscopy and virtual colonoscopy numbers after initiation of a CT colonography program: long term data. J Gastrointestin Liver Dis (2012) 2.00

Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96

Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev (2011) 1.90

Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology (2015) 1.89

Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut (2007) 1.79

Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep (2015) 1.72

Specialty differences in polyp detection, removal, and biopsy during colonoscopy. Am J Med (2010) 1.71

Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Gastroenterology (2014) 1.69

Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med (2014) 1.68

The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc (2014) 1.61

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer (2016) 1.55

Prospective randomized comparison of cold snare polypectomy and conventional polypectomy for small colorectal polyps. Digestion (2011) 1.53

Recommendations on screening for colorectal cancer in primary care. CMAJ (2016) 1.52

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Clin Gastroenterol Hepatol (2013) 1.52

Colorectal cancer screening in Europe. World J Gastroenterol (2009) 1.47

Sessile serrated polyps at screening colonoscopy: have they been under diagnosed? Am J Gastroenterol (2014) 1.45

Optimising the expansion of the National Bowel Cancer Screening Program. Med J Aust (2014) 1.45

Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology (2007) 1.44

Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol (2011) 1.43

Risk of Advanced Adenomas in Siblings of Individuals With Advanced Adenomas: A Cross-Sectional Study. Gastroenterology (2015) 1.42

Flexible sigmoidoscopy plus air-contrast barium enema versus colonoscopy for evaluation of symptomatic patients without evidence of bleeding. Gastrointest Endosc (1995) 1.42

Risk of cancer in small and diminutive colorectal polyps. Dig Liver Dis (2016) 1.40

Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer. Gastroenterology (2015) 1.40

Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev (2012) 1.36

Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act". Am J Clin Pathol (2006) 1.36

Cost-effectiveness of capsule endoscopy in screening for colorectal cancer. Endoscopy (2008) 1.28

The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform Decis Mak (2008) 1.18

The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomarkers Prev (2009) 1.18

Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies. Am J Gastroenterol (2016) 1.17

Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci (2014) 1.15

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10

Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc (2014) 1.07

Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study. Eur J Gastroenterol Hepatol (2010) 1.06

Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol (2014) 1.02

Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol (2014) 1.01

Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology (2014) 1.01

Articles by these authors

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol (2014) 4.25

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol (2015) 3.19

Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2014) 1.28

Split-dose administration of a dual-action, low-volume bowel cleanser for colonoscopy: the SEE CLEAR I study. Gastrointest Endosc (2013) 1.14

Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance. Gut (2015) 0.87

ACG colorectal cancer prevention action plan: update on CT-colonography. Am J Gastroenterol (2006) 0.85

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2016) 0.85

Effect of an endoscopic quality improvement program on adenoma detection rates: A multicenter cluster-randomized controlled trial in a clinical practice setting (EQUIP-3). Gastrointest Endosc (2016) 0.77

Response. Gastrointest Endosc (2015) 0.75

Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2017) 0.75

A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Am J Gastroenterol (2017) 0.75

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc (2017) 0.75